TrialAnnals of the American Thoracic Society2021

A Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis.

Timothy S Blackwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.